Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Prenatal Multi-Micronutrient Supplementation and Pregnancy Outcome
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: Bandim Health Project
Royal Veterinary and Agricultural University, Denmark
Information provided by: Bandim Health Project
ClinicalTrials.gov Identifier: NCT00168688
  Purpose

Prenatal maternal micronutrient supplementation has been suggested as a means to reduce the proportion of low birth weight babies in low-income countries. The effects of prenatal multi-micronutrient supplements on birth weight and perinatal mortality were studied in a randomised controlled trial among 2100 pregnant women in Guinea-Bissau. Women up to 37 weeks pregnant were individually randomised to daily supplements until delivery of A) Iron + folic acid or multi-micronutrients in B) One or C) Two recommended dietary allowances. Secondary outcomes were infant growth and maternal haemoglobin eight weeks after delivery.


Condition Intervention Phase
Nutrition
Micronutrients
Pregnancy
Birth Weight
Drug: multi-micronutrients
Phase I

MedlinePlus related topics: Dietary Supplements Prenatal Care
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: The Effects of Prenatal Multi-Micronutrient Supplements on Pregnancy Outcome, Peri- and Neonatal Mortality on Maternal and Infant Nutritional Status: A Randomised, Controlled Trial Among Women in Guinea-Bissau

Further study details as provided by Bandim Health Project:

Primary Outcome Measures:
  • Birth weight (<3 days)
  • Perinatal mortality

Secondary Outcome Measures:
  • Maternal haemoglobin (8 weeks pp)
  • Maternal anthropometry (8 weeks pp)
  • Infant growth (8 weeks pp)

Estimated Enrollment: 2100
Study Start Date: January 2001
Estimated Study Completion Date: October 2002
Detailed Description:

Prenatal maternal micronutrient supplementation has been suggested as a means to reduce the proportion of low birth weight babies in low-income countries. The effects of prenatal multi-micronutrient supplements on birth weight and perinatal mortality were studied in a randomised controlled trial among 2100 pregnant women in Guinea-Bissau. Women up to 37 weeks pregnant were individually randomised to daily supplements until delivery of identically looking tablets containing 1) Iron (60 mg) + folate (400 µg), 2) One recommended dietary allowance (RDA) of 5 minerals and 10 vitamins, including iron (30 mg) and folate (400 µg), or 3) Two RDA’s of 5 minerals and 10 vitamins, including iron (30 mg) and folate (800 µg). Supplements were provided in known excess at fortnightly home visits until delivery. Compliance was assessed by tablet count.

Women were interviewed about age, civil status, obstetric history and socio-economic status at enrolment. Maternal anthropometry was measured at enrolment, at delivery, and eight weeks after delivery. Maternal malaria parasitaemia and haemoglobin were measured at enrolment and eight weeks after delivery. Maternal status of a wide range of micronutrients was assessed at enrolment and eight weeks after delivery in a sub-cohort of 600 women. Further, survival of the infants will be followed until 3 years of age, within the routines of the Bandim Health Project surveillance system.

Women were provided impregnated bed nets and weekly malaria prophylaxis until delivery. Women with high malaria parasitaemia at enrolment were in addition given a full treatment at enrolment.

Sample size considerations: A sample size of 638 women in each treatment group will be required to detect a reduction in perinatal mortality from 9% to 5% or less in a treatment group using 80% power and a 5% significance level. With an expected loss to follow up of 10%, 2100 women are required. With a sample size of 2100 the study will be able to detect at least 75 g difference, i.e. a 2.5% change in birth weight.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pregnant women

Exclusion Criteria:

  • >37 weeks of gestational at enrollment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00168688

Locations
Guinea-Bissau
Bandim Health Project
Bissau, Guinea-Bissau, Apartado 861
Sponsors and Collaborators
Bandim Health Project
Royal Veterinary and Agricultural University, Denmark
Investigators
Study Director: Peter Aaby, Dr. Med Bandim Health Project
  More Information

Publications of Results:
Study ID Numbers: RUF-2001-91057-PREGNUT
Study First Received: September 13, 2005
Last Updated: October 4, 2006
ClinicalTrials.gov Identifier: NCT00168688  
Health Authority: Guinea-Bissau: Ministry of Health

Keywords provided by Bandim Health Project:
micronutrient supplementation
pregnancy
birth weight
perinatal mortality

Study placed in the following topic categories:
Body Weight
Birth Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on January 13, 2009